NCT02512471View on ClinicalTrials.gov

The Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Supraclavicular Brachial Plexus Block
Interventions
DRUG

Ropivacaine

brachial plexus block with ropivacaine 0.275%, MEV90 for USG-SCB (young group) brachial plexus block with ropivacaine 0.325%, MEV90 for USG-SCB (middle-aged group)

Trial Locations (1)

430030

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Huazhong University of Science and Technology

OTHER

NCT02512471 - The Minimum Effective Volume of Ropivacaine in Ultrasound-guided Supraclavicular Block | Biotech Hunter | Biotech Hunter